Granules India gets USFDA approval for Butalbital, Acetaminophen, Caffeine Capsules Medical Dialogues Bureau10 April 2020 6:31 AM GMTButalbital, Acetaminophen and Caffeine Capsules are used for the relief of the symptom complex of tension headache.
Granules receives USFDA nod for Potassium Chloride Extended-Release Tablets USP Medical Dialogues Bureau7 March 2020 4:30 AM GMTPotassium Chloride ER Tablets are used for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom...
Granules India gets 2 USFDA observations for Chantilly facility Medical Dialogues Bureau23 Aug 2019 6:16 AM GMT"The United States Food and Drug Administration (USFDA) has completed inspection of the facility of Granules Pharmaceuticals Inc, a wholly-owned...
Granules India completes USFDA inspection for Bonthapally facility with one observation Farhat Nasim29 July 2019 4:30 AM GMTGranules India Ltd's Bonthapally facility is one of the world's largest single-site Paracetamol API manufacturing plant by volume. New Delhi: Drug...
Granules India gets USFDA nod for Methylphenidate Hydrochloride ER capsules Farhat Nasim28 May 2019 4:30 AM GMTThe approved product, Methylphenidate Hydrochloride extended-release capsules, is bioequivalent to the reference listed drug product (RLD), Ritalin LA...
Granules gets 2 observation by USFDA for U.S Unit Medical Dialogues Bureau30 Oct 2018 5:18 AM GMTNew Delhi: Pharma firm Granules through a recent regulatory filing announced its US subsidiary has received two observations from the US health...